fibromyalgia
Conditions
Interventions
Treatment with QPA (2.5 hours once, once a week, 5 times in total)
Sponsors
Tokushima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients diagnosed with fibromyalgia according to the American College of Rheumatology (ACR) Fibromyalgia Preliminary Diagnostic Criteria (2010) Prevalence period 6 months or more
Exclusion criteria
Exclusion criteria: Patients with implantable electronic devices (such as pacemakers) Patients with serious heart disease, kidney disease, liver disease Patients with arterial oxygen saturation <94% without oxygen Patients with severe peripheral neuropathy Persons who have lost temperature sensitivity Patients who cannot express their intention Patients with hypersensitivity, injury or lesions on the skin of the pad area (upper back and lower back) Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of the Japanese version of the Revised Fibromyalgia Impact Questionnaire (JFIQR) before and 4 weeks after the start of QPA treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes in JFIQR domain (1), (2), (3) and each item before and 4 weeks after the start of QPA treatment | — |
Countries
Japan
Contacts
Public ContactHarutaka Yamaguchi
Tokushima University Graduate School of Biomedical Sciences Department of General Medicine
Outcome results
None listed